Related Experiment Video
Updated: Sep 15, 2025

Intravital Microscopy and Thrombus Induction in the Earlobe of a Hairless Mouse
Published on: April 2, 2017
Rosa Centifolia L. effect on hemostasis: a multifaceted study combining in-vitro, in-vivo, and in-silico
Omayma El Meziouy1, Moulay Hfid Youssoufi2, Ali Berraaouan1
1Laboratory of Bioinformatics, Department of Bioinformatics, Biocenter, Würzburg University, Würzburg.
Abstract:
Thrombus formation is a major cause of cardiovascular disease-related death. Traditional medicine has long utilized plants for therapeutic purposes. The aqueous extract of Rosa centifolia L., commonly used in Moroccan folk medicine, was investigated for its potential anticoagulant and antioxidant properties. The study assessed platelet aggregation inhibition, bleeding time, antioxidant activity, and coagulation parameters, including activated partial thromboplastin time (aPTT), prothrombin time (PT), and fibrinogen concentration. Platelet aggregation was induced using thrombin, ADP, arachidonic acid, and collagen. Antioxidant activity was evaluated using the FRAP and β-carotene assays. Phytochemical analysis identified the presence of phenols, flavonoids, and tannins. Additionally, computational molecular docking was performed to analyze the interaction between prostaglandin G/H synthase 1 (COX-1) and kaempferol. The aqueous extract significantly inhibited platelet aggregation and prolonged bleeding time, particularly at 1 mg/ml, where it also extended aPTT. Antioxidant activity was confirmed through FRAP and β-carotene assays. Computational docking of kaempferol with COX-1 generated 10 binding modes, demonstrating favorable binding affinities and validating the docking protocol using the co-crystallized diclofenac structure. The findings suggest that Rosa centifolia L. exhibits anticoagulant and antioxidant properties, supporting its potential therapeutic application in preventing oxidative stress and thrombosis-related disorders.
Related Concept Videos
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...

